Anila Lingamneni is CTO & VP at HAEMONETICS CORP (HAE). They have made 5 open-market trades across 1 company since 2021, most recently 2024-07-12.
CIK 0001808414
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HAE | 21,331 | $2.7M |
Shares reported on the most recent Form 4, priced at the 2024-07-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HAE | SELL · 10b5-1 | 2024-07-11 | 2024-07-15 | $90.00 | $199K | +0.1% | -19.2% | -16.8% |
| HAE | SELL · 10b5-1 | 2024-05-06 | 2024-05-08 | $95.00 | $219K | +4.9% | -5.7% | -5.1% |
| HAE | SELL · 10b5-1 | 2023-09-11 | 2023-09-13 | $90.00 | $207K | +1.7% | -0.8% | -4.0% |
| HAE | SELL | 2023-05-30 | 2023-06-01 | $83.33 | $384K | -0.2% | -3.6% | +3.9% |
| HAE | SELL | 2022-05-19 | 2022-05-23 | $59.10 | $164K | +6.2% | +0.3% | +25.8% |
| HAE | SELL | 2022-04-18 | 2022-04-19 | $56.55 | $11K | -11.2% | +5.5% | +11.4% |
| HAE | SELL | 2021-05-19 | 2021-05-20 | $55.19 | $5K | -1.9% | +11.3% | +2.9% |
| HAE | SELL | 2021-04-16 | 2021-04-20 | $119.44 | $20K | +1.3% | -14.5% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.